City

Shanghai (1)

Condition

ALK Negative NSCLC (1)

EGF-R Negative Non-Small Cell Lung Cancer (1)

NSCLC, Stage IIIA (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Tongji University (1)

Collaborator

Intervention

pd-1 and chemotherapy (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

alk negative nsclc

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, Stage IIIA, EGF-R Negative NSCLC, ALK Negative NSCLC Trial in Shanghai (PD-1 and chemo)

Recruiting

NSCLC, Stage IIIA
+2 more

PD-1 and chemotherapy

Shanghai, Shanghai, China

Shanghai General Hospital

Dec 14, 2021